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Soluble products of cultured adherent cells of mononucleat phagoeyte-macrophage 
(Mth)  lineage have been shown to be involved in the in vitro activation of thymus- 
derived  (T)  lymphocytes by  mitogen  (1-5)  and  more  recently,  by  antigen  (6,  7). 
Although the function of such products is undefined in vivo, it is tempting to speculate 
that such  factors play a  significant role in the viability, differentiation, and immu- 
nologic reactivity of the lymphoid organ of the intact animal. 
Leukocytic pyrogen  (LP),  a  soluble  product  of bone marrow-derived phagocytic 
cells has been shown to have a  precise in vivo activity, namely, the mediation of the 
febrile response (8). In addition, recent advances have allowed for the ready acquisition 
of highly purified human LP derived from peripheral blood monocytes (9-11). In this 
report,  by  utilizing  a  Mth-dependent,  antigen-specific  murine  T-cell  proliferation 
assay, we have examined the ability of human LP to partially replace intact murine 
peritoneal exudate cells (PEC)  as well as soluble products of murine PEC in the T- 
cell proliferative response to antigen. 
Materials and Methods 
Animals.  BI0.A/SgSn J  (B10.A), and C57BL/6 (B6) mice were obtained from The Jackson 
Laboratory, Bar Harbor, Maine. Where possible, only female mice between 8 and 24 wk of age 
were used. 
Antigens.  The dinitrophenyl  (DNP)  conjugate  of egg albumin  (OVA)  was  prepared as 
described  elsewhere  (12). The conjugate contained  13  moles of DNP  per mole of protein 
(DNPlaOVA). Crude keyhole limpet hemocyanin, (KLH, Bin Marine Industries, Inc., Malvern, 
Pa.)  was purified by repeated uhracentrifugation and used in the associated  form. 
Immunization.  Mice  were  immunized  by injections of 0.05  ml  per hind  foot  pad of an 
emulsion of antigens and complete Freund's adjuvant  (CFA)  containing  1 mg/ml of killed 
Mycobacterium tuberculosis (H37Ra, Difco Laboratories, Detroit, Mich.);  10/~g of DNPlaOVA or 
of KLH were present in 0.1  ml of emulsion. Boost  immunization of equivalent amounts of 
antigen in CFA was performed 2-3 wk after priming. 
Cell-Culture  Technique.  The  method  for  assaying  Mq~-dependent,  antigen-specific  T-cell 
proliferation has been described elsewhere  (6, 7). Briefly, naive mice are primed with antigen 
in CFA in the hind foot pads and boosted with equivalent antigen in CFA 14-21 d later. 1-4 
wk after that, the popliteal and femoral lymph nodes are removed, teased, and pressed through 
a No. 200 wire-mesh screen and incubated on a nylon-wool adherence column for 60 rain. On 
elution, a T-cell enriched, adherent cell-depleted population of immune lymph node lympho- 
cytes (LNL) is obtained. This population contains 90-95% T cells, 1-5% B cells, and 0.1-0.5% 
c- 
THE JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME  150, 1979  709 710  ROSENWASSER ET AL.  BRIEF  DEFINITIVE  REPORT 
M~. The immune LNL are then incubated with or without antigen, or reconstituting PEC 
(sterile, mineral oil-induced, mitomycin C-treated cells from nonimmune  donors) as a source of 
Mq~. In some experiments, other accessory additions to culture than PEC are used. Cultures are 
carried out in flat-bottom microtiter plates with 2  ×  105 LNL and 5  ×  104 PEC per well in a 
vol  of 200  /zl  of RPMI-1640 medium  (Grand Island Biological Co.,  Grand Island, N.  Y.) 
supplemented with fresh L-glutamine (0.3 mg/ml), gentamicin (10/~g/ml), penicillin (200 U/ 
ml), 2-mercaptoethanol (2.5 ×  10  -5 M), 10 mM Hepes buffer, and 7.5% fetal calf serum (FCS). 
The cultures were carried out at 37°C in humidified atmosphere of 5% CO2 and 95% air for 96 
h.  16-24 h before harvesting, 1/zCi of tritiated thymidine ([ H]TdR, 6.7 Ci/mM New England 
Nuclear,  Boston,  Mass.)  was  added  per  well.  [aH]TdR  incorporation was  measured  after 
harvesting, by liquid scintillation spectrometry and the results reported as mean counts per 
minute +  SEM for triplicate determination or as the number of counts above control (Acpm); 
e.g., experimental (aggregated) -  control (no aggregation). All washing procedures were done 
in Hanks' balanced salt solution (Grand Island Biological  Co.). 
Preparation of PEC Supernates.  Murine PEC were cultured at a concentration of 1.0-2.0  X 
106/ml in supplemented RPMI-1640. After 24-h incubation at 37°C, supernates were collected, 
centrifuged at  1,000 g  for 20  min, and filtered through a  45-#m Millipore filter (Millipore 
Corp., Bedford, Mass.)  to remove any contaminating cells. These PEC supernates were then 
used as an accessory addition to murine-LNL culture. 
Preparation of Human Adherent Cells (Mdp).  The method for preparing human Mq~ has been 
described elsewhere  (13).  Briefly,  venous blood was obtained from healthy adults taking no 
medications at  the  time  of study.  The  mononuclear cell  population was  obtained  from 
heparinized whole blood by centrifugation on Hypaque-(Winthrop Laboratories, New York) 
Ficoll  (Pharmacia  Fine Chemicals,  Div.  of  Pharmacia,  Inc.,  Piscataway,  N.  J.)  cushions. 
Resultant peripheral blood mononuclear cells  (PBM)  consisted of 70-85% lymphocytes and 
15-30% monocytes. PBM were then cultured on sterile glass Petri dishes in complete medium 
for  60 min at  37°C.  After this incubation, the nonadherent cells  were discarded. The cells 
adherent to glass were then reincubated in complete medium for 30 rain at 37°C after which 
they were  vigorously washed.  The adherent cells  remaining after these washings were then 
bathed in chilled phosphate-buffered saline (PBS), chilled to 4°C, and dislodged from the Petri 
dishes with a  sterile rubber policeman. After washing, the cells were suspended in medium, 
exposed to 40/zg/ml mitomycin C for 60 min at 37°C and washed four times. More than 90% 
of the resulting cell population was judged to be monocytes and macrophages by morphologic 
or phagocytic criteria. Trypan-blue viability was :>95%. These human Mq, were then added as 
accessory cells to cultures of murine LNL or they were placed in culture for 24 h and supernates 
prepared in a manner analogous to the method of preparation of supernates from murine PEC. 
Preparation of Human  LP.  Crude  supernates  were  prepared  from  mononuclear cells  as 
described previously (8). Crude supernates containing LP were concentrated in autoclaved 
dialysis tubing in front of a  high-speed fan. Volumes were reduced 1~0 and dialyzed against 
PBS with 0.02% sodium azide. Concentrated LP was passed over an immunoadsorbent rabbit 
anti-human LP antibody attached to cyanogen bromide-activated Sepharose (Pharmacia Fine 
Chemicals, Div. of Pharmacia, Inc.). LP was eluted from this material in citric-acid buffer, pH 
3.2 (9), neutralized with 0.1  M NaOH and stored in 0.02% sodium azide. LP eluted from the 
anti-LP immunoadsorbent  was concentrated and chromatographed over Sephadex G-50 (Phar- 
macia Fine Chemicals, Div. of Pharmacia, Inc. [fine];  165 ×  5.6 era) at 4°C in PBS with 0.02% 
sodium azide. The 15,000-mol wt LP peak was isolated, dialyzed against H~O and lyophilized: 
this material gave a single staining band on 7.5% sodium dodecyl sulfate polyacrylamide gels 
(11). This material was used as the source of human LP described in the experiments in Table 
I. About 20 ng of purified pyrogen protein were added to each well containing adherent cell- 
depleted LNL and/or antigen. 
Further purification of human LP was carried out using 125I-labeled LP (10, 11). Approxi- 
mately 25% of the LP eluting from both the immunoadsorbent and gel filtration was labeled 
with x2sI (11). After this, LP was chromatographed over Sephadex G-15 (40 ×  1.5 cm) in PBS. 
Further purification of the LP isolated from Sephadex G-15 was carried out using ion-exchange 
chromatography on DEAE-cellulose in 0.02 M Tris, pH 8.1, at 4°C. Labeled LP eluted during 
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TABLE  I 
Proliferative Response of Immune B I O.A LNL Reconstituted by Various Accessory Additions to Culture* 
Accessory addition to culture 
[ZH]TdR incorporations 
200 #g/ml  Baseline§ 
DNP~3OVA 
Acpm X  10 -3 
None  0.79 ±  0.29  0.87  ±  0.62 
BI0.A PEC  20.88  ±  3.00  1.63 ±  1.35 
B6 PEC  17.31 ±  4.01  5.48  +  1.83 
BI0.A PEC supernate  10.04 ±  3.26  1.36 4-  1.06 
B6 PEC supernate  9.20 ±  3.16  1.03 ±  0.81 
Human M~b  9.58 ±  2.31  1.07 4- 0.35 
Human M~ supernate  8.79 4-  1.36  1.89 ±  0.29 
Human lymphocyte supematell  0.13  4- 0.06  1.22 ±  0.11 
Cycloheximide-treated human Mq~ supernate  u  0.48  ±  0.21  1.51  ±  0.23 
HSA (o.1%)11  0.37 ± 0.20  2.05  ±  0.44 
LP¶  7.06 ±  1.14  1.66 ±  1.30 
LP**  8.10 ±  0.23  0.16 ±  0.02 
* 2  X  10  5 LNL, accessory addition to culture, with or without antigen cultured per well for 4 d in flat-bottom microtiter 
plates, 
:~ Acpm: experimental (aggregated) -  baseline (no aggregation). Data is expressed as mean Acpm  x  10  -3  ±  SE for six 
experiments. 
§ Baseline represents incorporation of [SH]TdR in mixtures of LNL with various accessory additions to culture, without 
antigen. Expressed as mean cpm X  10  -3  ±  SE for six experiments or for two experiments. 
II Indicates Acpm X  10  -3  ±  SE for two experiments. 
I  Human LP purified by immunoabsorption and gel filtration. 
** Results of a single representative experiment with human LP further purified by ion-exchange chromatography and 
isoelectric focusing. Data are expressed as mean Acpm X  10  -a of replicate samples. 
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125  Fie.  I.  Isoelectric focusing of  I-labeled human  LP.  1% Ampholine (pH  3-10) and 4.5% acryl- 
amide. Gel lengths were 2.5  X  10 mm. Constant voltage, 200 V, was applied for  18 h  at 4°C. Gels 
were cut every 2 mm and radioactivity and pH were measured on each fraction. 
1%  Ampholine  (LKB  Instruments,  Inc.,  Rockville,  Md.,  pH  3-10),  a  homogeneous  peak  of 
radioactivity  occurred  at pH  7.0-7.1  (Fig.  1). 
A  small  quantity  of this radiolabeled  LP  (m 1,000 cpm)  was added  to unlabeled  LP  isolated 
from  Sephadex  G-50.  This  material  was  chromatographed  over  Sephadex  G-15  followed  by 
DEAE  ion  exchange  and  in each  case,  the  radioactivity  peak  was  used  to  indicate  unlabeled 
LP.  Because  biologic activity  decreased  significantly  during  the  ion  exchange  step,  0.1%  salt- 712  ROSENWASSER  ET  AL.  BRIEF  DEFINITIVE REPORT 
poor human serum albumin  (HSA) was added  to each collection tube to prevent nonspecific 
adsorption.  Recovery of biologic activity was between  1 and  2% of the starting concentrated 
crude LP. 
Results 
Antigen-induced Activation of Immune B I O.A  T  Cells by Added Adherent Accessory Cells or 
Soluble Products of Adherent Cells.  In previous reports (6, 7) an adherent cell-dependent, 
antigen-specific murine T-cell proliferation assay was employed to delineate at least 
two  functions  for  M~  in  the  antigen-recognition  process.  One  function  may  be 
discerned in the T-cell proliferative response to multideterminant antigens  (DNPIa- 
OVA, KLH) where the response is dependent on the production of a soluble factor 
which  is  neither antigen specific nor H-2 restricted;  therefore allogeneic Mq~s may 
reconstitute  the  response  and  supernates  of cultured  adherent  cells  may  partially 
replace the response. A  second activity is seen when the proliferation of immune T 
cells to the terpolymers GLT  15 or GL~  9 are examined. This response is reconstituted 
only with Mq~ which have identity or partial identity at H-2 with the primed T  cells, 
suggesting a  specific genetically restricted antigen-presentation function for macro- 
phages. This latter Mq~ function has been discussed elsewhere and will not be discussed 
any further in this communication (7,  14). 
The data in Table I examine the proliferative response of immune B10.A T  cells to 
multideterminant  antigens  (DNP13OVA,  KLH)  and  the effect of various accessory 
additions to culture. As can be seen, syngeneic and allogeneic PEC reconstitute the 
response of the  T  cells  to  protein  antigens.  Additionally,  murine  PEC  supernates 
partially restore the response. Quite surprisingly, intact human Mq~ as well as human 
M~ supernates, also reconstitute antigen responsiveness. However, human lymphocyte 
supernates, cycloheximide-treated human M~ supernates and HSA will not support 
proliferation. Human  LP, purified by immunoabsorption  and  gel filtration clearly 
enhanced the proliferative capacity of macrophage-depleted B10.A LNL. Finally, in 
a  representative experiment, LP further purified by ion-exchange chromatography 
and isoelectric focusing was also found to be active. In data not shown, DNO13OVA 
and human LP together will not stimulate T  cells primed to another antigen. 
Discussion 
Soluble products of cultured mononuclear phagocytes of both mice and humans 
have been shown  to be involved in the activation of T  cells  (1-5,  15,  16).  In  this 
report, we have found that  partially purified human  LP, an adherent cell product 
that  has  been  biochemically  analyzed  (8-11),  will  enhance  the  M~dependent, 
antigen-specific activation and clonal expansion of immune T  cells. Extensive purifi- 
cation of the human LP did not remove the T-cell stimulatory activity. Additionally, 
both intact human M~ and supernates derived from human M~-enhanced murine T- 
cell antigen recognition. It is reasonable to assume that human M~ and murine PEC 
supernates contain human lymphocyte-activating factor (LAF) or a  family of LAF- 
like  molecules  which  are  critical  for  the  amplification  of antigen-induced  T-cell 
activation. Furthermore, human LP seems to be functionally identical or related to 
these molecules. 
While  a  simplistic  comparison  of results  obtained  from  different  laboratories 
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from the numerous observations made concerning the properties of murine LAF or 
mitogenic factor (1-5,  17-19), human LAF (15,  16,  18, 20), or human LP (8-11, 21) 
which  suggest  biochemical  or  functional  similarities  among  these  molecules.  The 
obvious pitfalls of such comparisons include differences in assay techniques, evidence 
that both the charge and molecular weight of some of these three products may be 
heterogeneous,  and  the  possibility  that  there  may  exist  cross-reactive  biological 
function  between  three  distinct  yet  similar  molecules.  Nonetheless,  murine  LAF, 
human  LAF,  and  human  LP are all  produced  by activated Mt~ monocytes, where 
activation implies either a phagocytic stimulus, LPS, or an interaction with activated 
lymphocytes or their products.  The macrophage tumor cell  line  P388D1,  has been 
shown to spontaneously produce LAF (4, 5) as well as pyrogen, as noted in the study 
of Bodel  (22).  Murine  LAF,  human  LAF,  and  human  LP  all  have similar  if not 
identical molecular weights (14,000-16,000)  and have, as well, similar cycloheximide 
sensitivity.  Additionally,  human  LAF  and  human  LP  have  essentially  identical 
isoelectric focusing points (6.8-7.0). A  recent report (19)  has demonstrated a  murine 
LAF with an isoelectric focusing point of 4.8, however, the mol wt of their LAF was 
in the range of 18,000-19,000. 
The findings  in our studies  that soluble products of adherent  cells may augment 
antigen-specific T-cell reactivity and that such LAF-like functions may be substituted 
for by highly purified human LP. On the basis of biochemical similarities as well as 
by functional characteristics it is tempting to speculate that some, if not all, LAF-like 
activity is due to Leukocytic Pyrogen. 
Summary 
A  macrophage-dependent,  antigen-specific  murine T-cell proliferation  assay was 
utilized to examine the role of soluble products of murine and human adherent cells 
in the activation of T  lymphocytes. Highly purified human leukocytic pyrogen, and 
supernates  from  both  murine  and  human  mononuclear  phagocytes-macrophages 
stimulated the immune T-cell proliferative response to the multideterminant antigens 
dinitrophenyl-ovalbumin and keyhole limpet hemocyanin. The implications of these 
studies and the relationship of leukocytic pyrogen to human lymphocyte-activating 
factor are discussed. 
Received  for publication 12 March 1979. 
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